NEOPHARM, Inc. (Nasdaq: NEOL) announced the presentation of final Phase 1 safety results at the Society for Neuro-Oncology (SNO) 11th ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE